We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Explore Vir Biotechnology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VIR. Vir Biotechnology's Phase 1 data highlights early promise for T-cell ...
Barclays analyst Gena Wang raised the firm’s price target on Vir Biotechnology (VIR) to $31 from $26 and keeps an Overweight rating on the shares following the Q4 report. See what stocks are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback